Abstract P6-11-03: Beyond the Second Line Chemotherapy in Metastatic Breast Cancer: When Stop the Treatment between Science and Conscience

Metastatic Breast ◽

Second Line ◽

Abstract PS13-31: Prospective observational study to explore the effectiveness of eribulin as first- or second- line chemotherapy in patients with HER2-negative hormone-resistant advanced or metastatic breast cancer (KBCRN A001: E-SPEC study)

10.1158/1538-7445.sabcs20-ps13-31 ◽

2021 ◽

Author(s):

Yuri Fujimoto ◽

Yuichiro Kikawa ◽

Takeshi Kotake ◽

Shigeru Tsuyuki ◽

Sachiko Takahara ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Prospective Observational Study ◽

Metastatic Breast ◽

Second Line ◽

230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based Treatment

European Journal of Cancer ◽

10.1016/s0959-8049(12)70298-8 ◽

2012 ◽

Vol 48 ◽

pp. S109-S110

Author(s):

H.K. Chang ◽

Y.C. Lin ◽

K.M. Rau ◽

Y.Y. Chen ◽

K.D. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Second Line ◽

Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

Value in Health ◽

10.1016/j.jval.2014.08.2289 ◽

2014 ◽

Vol 17 (7) ◽

pp. A637

Author(s):

I. Krysanov ◽

V. Krysanova

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Metastatic Breast ◽

Cost Effectiveness Analysis ◽

Second Line ◽

Effectiveness Analysis ◽

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-007-0259-0 ◽

2007 ◽

Vol 134 (2) ◽

pp. 125-135 ◽

Cited By ~ 9

Author(s):

Martina Baur ◽

Allan T. van Oosterom ◽

Véronique Diéras ◽

Michele Tubiana-Hulin ◽

R. Charles Coombes ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Second Line ◽

A phase II, multicenter, single-arm trial of eribulin as first or second line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported outcomes.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13059 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13059-e13059 ◽

Cited By ~ 2

Author(s):

Mitsuhiko Iwamoto ◽

Kosei Kimura ◽

Satoru Tanaka ◽

Daigo Yamamoto ◽

Katsuhide Yoshidome ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Patient Reported Outcomes ◽

Metastatic Breast ◽

Second Line ◽

Patient Reported ◽

A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast Cancer

PharmacoEconomics ◽

10.2165/00019053-199610050-00008 ◽

1996 ◽

Vol 10 (5) ◽

pp. 504-521 ◽

Cited By ~ 57

Author(s):

Robert Launois ◽

Jeanne Reboul-Marty ◽

Bernadette Henry ◽

Jacques Bonneterre

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Cost Utility ◽

Cost Utility Analysis ◽

Second Line ◽

Utility Analysis ◽

Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2

European Journal of Cancer ◽

10.1016/s0959-8049(99)81709-2 ◽

1999 ◽

Vol 35 ◽

pp. S322

Author(s):

H.A. Burris ◽

J.D. Hainesworth ◽

K. Albain ◽

M. Huntington ◽

F.A. Greco ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Second Line ◽

Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer

Breast Cancer Research and Treatment ◽

10.1023/a:1026360621622 ◽

2003 ◽

Vol 81 (S1) ◽

pp. 33-36 ◽

Cited By ~ 1

Author(s):

Christoph C. Zielinski

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Second Line ◽

Treatment Choices ◽

P917. Taxol and fluorouracil as second line chemotherapy for metastatic breast cancer

The Breast ◽

10.1016/s0960-9776(97)90088-6 ◽

1997 ◽

Vol 6 (5) ◽

pp. 335

Author(s):

A. Fornasiero ◽

C. Ghiotto ◽

O. Daniele ◽

P. D'Amanzo ◽

S.M.L. Aversa ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Second Line ◽

Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer

Supportive Care in Cancer ◽

10.1007/s00520-008-0558-2 ◽

2009 ◽

Vol 17 (8) ◽

pp. 1081-1088 ◽

Cited By ~ 7

Author(s):

Lee S. Schwartzberg ◽

Patrick Cobb ◽

Mark S. Walker ◽

Edward J. Stepanski ◽

Arthur C. Houts

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Second Line ◽